Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,636,072
-
Share change
-
-1,797,051
-
Total reported value
-
$43,008,475
-
Price per share
-
$1.90
-
Number of holders
-
44
-
Value change
-
-$4,132,929
-
Number of buys
-
19
-
Number of sells
-
28
Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) as of Q1 2021
As of 31 Mar 2021 LEAP THERAPEUTICS INC - COM (LPTX) had 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,636,072 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, HILLHOUSE CAPITAL ADVISORS, LTD., Artal Group S.A., VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, TWO SIGMA ADVISERS, LP, BAKER BROS. ADVISORS LP, JACOBS LEVY EQUITY MANAGEMENT, INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and Opaleye Management Inc..
This table shows 44 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.